¶ MBD5 Protein - Methyl-CpG Binding Domain Protein 5
| MBD5 Protein |
|---|
| Protein Name | Methyl-CpG Binding Domain Protein 5 |
| Gene | MBD5 |
| UniProt ID | Q9P2T1 |
| Category | Epigenetic Regulator Protein |
| Path | /proteins/mbd5-protein |
MBD5 (Methyl-CpG Binding Domain Protein 5) is a chromatin-associated protein that plays a critical role in epigenetic regulation, neurodevelopment, and synaptic function. It is encoded by the MBD5 gene and is highly expressed in the brain, particularly during development. Mutations in MBD5 are a well-established cause of neurodevelopmental disorders including autism spectrum disorder (ASD) and intellectual disability (ID).
MBD5 contains several functional domains:
- Methyl-CpG binding domain (MBD): Located at the N-terminus, this domain binds specifically to methylated CpG dinucleotides
- Proline-rich region: Mediates protein-protein interactions
- ATN domain (Atrophin-1-like): Shared with other MBD family members, involved in transcriptional regulation
- C-terminal region: Contains additional binding sites for chromatin-associated proteins
The protein has a molecular weight of approximately 225 kDa and localizes to the nucleus where it functions as a transcriptional regulator.
MBD5 acts as a transcriptional regulator through multiple mechanisms:
- DNA methylation binding: Recognizes methylated promoter regions and modulates gene expression
- Chromatin remodeling recruitment: Recruits histone modifiers and chromatin remodelers
- Gene-specific targeting: Regulates specific gene networks important for neuronal function
MBD5 is essential for normal brain development:
- Cortical development: Regulates neuronal proliferation and differentiation
- Synaptogenesis: Important for proper synapse formation and function
- Circuit formation: Guides development of neural circuits
- Dendritic arborization: Influences dendritic morphology
High expression in:
- Cerebral cortex: Throughout all cortical layers
- Hippocampus: Especially CA regions and dentate gyrus
- Cerebellum: Purkinje cells and granule cells
- Basal ganglia: Striatal medium spiny neurons
- Developing brain: Peak expression during prenatal and early postnatal development
MBD5 is one of the most significant ASD risk genes:
- Heterozygous mutations: Cause haploinsufficiency leading to ASD
- De novo variants: Predominantly de novo loss-of-function mutations
- Penetrance: High penetrance for neurodevelopmental phenotypes
- Phenotype spectrum: ASD with intellectual disability, speech delay
MBD5 mutations are a common cause of nonsyndromic intellectual disability:
- Severity: Ranges from mild to moderate ID
- Co-occurring features: Often with speech impairment
- Developmental trajectory: Early developmental delays, plateau in adolescence
Also known as MBD5-associated neurodevelopmental disorder (MAND):
- Epilepsy: Seizures in ~50% of cases
- Motor delays: Hypotonia, motor coordination issues
- Behavioral features: Anxiety, attention deficits, aggression
- Regression: Some individuals show developmental regression
- Insomnia: Common sleep initiation problems
- Circadian rhythm disturbances: Altered sleep-wake cycles
- Treatable: Some respond to melatonin therapy
- Mutation types: Missense, nonsense, frameshift, splice site
- Hotspots: Throughout the coding sequence
- Inheritance: Almost always de novo
- Genotype-phenotype: No clear correlation between mutation type and severity
MBD5 is the critical gene in 2q23.1 microdeletion syndrome:
- Contiguous gene deletion: Includes MBD5 and flanking genes
- Phenotype overlap: Similar to MBD5 point mutations
- Mechanism: Haploinsufficiency of MBD5
- Symptomatic treatment: Antiepileptic drugs for seizures
- Behavioral interventions: Applied behavior analysis (ABA)
- Speech therapy: Communication enhancement
- Occupational therapy: Motor skills development
- Epigenetic drugs: HDAC inhibitors under investigation
- Gene therapy: Future potential for precision medicine
- Targeted interventions: Understanding MBD5 downstream effects
- Knockout mice: Mbd5+/- mice show cognitive deficits
- Conditional knockouts: Brain-specific deletion replicates features
- Zebrafish: Developmental studies showing conserved function
- MBD5 in neurodevelopment and autism (2020)
- MBD5 encephalopathy: clinical features and genetics (2019)
- Epigenetic regulation in autism spectrum disorders (2021)
- 2q23.1 microdeletion syndrome (2018)
- Chromatin and neurodevelopmental disorders (2022)
- MBD5 and synaptic function (2021)